Literature DB >> 24501404

Identification of herpesvirus proteins that contribute to G1/S arrest.

Patrick Paladino1, Edyta Marcon, Jack Greenblatt, Lori Frappier.   

Abstract

UNLABELLED: Lytic infection by herpesviruses induces cell cycle arrest at the G1/S transition. This appears to be a function of multiple herpesvirus proteins, but only a minority of herpesvirus proteins have been examined for cell cycle effects. To gain a more comprehensive understanding of the viral proteins that contribute to G1/S arrest, we screened a library of over 200 proteins from herpes simplex virus type 1, human cytomegalovirus, and Epstein-Barr virus (EBV) for effects on the G1/S interface, using HeLa fluorescent, ubiquitination-based cell cycle indicator (Fucci) cells in which G1/S can be detected colorimetrically. Proteins from each virus were identified that induce accumulation of G1/S cells, predominantly tegument, early, and capsid proteins. The identification of several capsid proteins in this screen suggests that incoming viral capsids may function to modulate cellular processes. The cell cycle effects of selected EBV proteins were further verified and examined for effects on p53 and p21 as regulators of the G1/S transition. Two EBV replication proteins (BORF2 and BMRF1) were found to induce p53 but not p21, while a previously uncharacterized tegument protein (BGLF2) was found to induce p21 protein levels in a p53-independent manner. Proteomic analyses of BGLF2-interacting proteins identified interactions with the NIMA-related protein kinase (NEK9) and GEM-interacting protein (GMIP). Silencing of either NEK9 or GMIP induced p21 without affecting p53 and abrogated the ability of BGLF2 to further induce p21. Collectively, these results suggest multiple viral proteins contribute to G1/S arrest, including BGLF2, which induces p21 levels likely by interfering with the functions of NEK9 and GMIP. IMPORTANCE: Most people are infected with multiple herpesviruses, whose proteins alter the infected cells in several ways. During lytic infection, the viral proteins block cell proliferation just before the cellular DNA replicates. We used a novel screening method to identify proteins from three different herpesviruses that contribute to this block. Several of the proteins we identified had previously unknown functions or were structural components of the virion. Subsets of these proteins from Epstein-Barr virus were studied for their effects on the cell cycle regulatory proteins p53 and p21, thereby identifying two proteins that induce p53 and one that induces p21 (BGLF2). We identified interactions of BGLF2 with two human proteins, both of which regulate p21, suggesting that BGLF2 induces p21 by interfering with the functions of these two host proteins. Our study indicates that multiple herpesvirus proteins contribute to the cell proliferation block, including components of the incoming virions.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24501404      PMCID: PMC3993752          DOI: 10.1128/JVI.00059-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  71 in total

1.  Genetic dissection of cell growth arrest functions mediated by the Epstein-Barr virus lytic gene product, Zta.

Authors:  A Rodriguez; M Armstrong; D Dwyer; E Flemington
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

2.  The Epstein-Barr virus bZIP transcription factor Zta causes G0/G1 cell cycle arrest through induction of cyclin-dependent kinase inhibitors.

Authors:  C Cayrol; E K Flemington
Journal:  EMBO J       Date:  1996-06-03       Impact factor: 11.598

3.  Nuclear body formation and PML body remodeling by the human cytomegalovirus protein UL35.

Authors:  Jayme Salsman; Xueqi Wang; Lori Frappier
Journal:  Virology       Date:  2011-04-13       Impact factor: 3.616

4.  Human cytomegalovirus inhibits cellular DNA synthesis and arrests productively infected cells in late G1.

Authors:  W A Bresnahan; I Boldogh; E A Thompson; T Albrecht
Journal:  Virology       Date:  1996-10-01       Impact factor: 3.616

5.  The ribonucleotide reductase R1 subunits of herpes simplex virus types 1 and 2 protect cells against TNFα- and FasL-induced apoptosis by interacting with caspase-8.

Authors:  Florent Dufour; A Marie-Josée Sasseville; Stéphane Chabaud; Bernard Massie; Richard M Siegel; Yves Langelier
Journal:  Apoptosis       Date:  2011-03       Impact factor: 4.677

6.  Human cytomegalovirus infection inhibits cell cycle progression at multiple points, including the transition from G1 to S.

Authors:  M Lu; T Shenk
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

7.  Sequential Peptide Affinity (SPA) system for the identification of mammalian and bacterial protein complexes.

Authors:  Mahel Zeghouf; Joyce Li; Gareth Butland; Anna Borkowska; Veronica Canadien; Dawn Richards; Bryan Beattie; Andrew Emili; Jack F Greenblatt
Journal:  J Proteome Res       Date:  2004 May-Jun       Impact factor: 4.466

8.  Ras promotes p21(Waf1/Cip1) protein stability via a cyclin D1-imposed block in proteasome-mediated degradation.

Authors:  Mathew L Coleman; Christopher J Marshall; Michael F Olson
Journal:  EMBO J       Date:  2003-05-01       Impact factor: 11.598

9.  Visualizing spatiotemporal dynamics of multicellular cell-cycle progression.

Authors:  Asako Sakaue-Sawano; Hiroshi Kurokawa; Toshifumi Morimura; Aki Hanyu; Hiroshi Hama; Hatsuki Osawa; Saori Kashiwagi; Kiyoko Fukami; Takaki Miyata; Hiroyuki Miyoshi; Takeshi Imamura; Masaharu Ogawa; Hisao Masai; Atsushi Miyawaki
Journal:  Cell       Date:  2008-02-08       Impact factor: 41.582

10.  EAPP modulates the activity of p21 and Chk2.

Authors:  Peter Andorfer; Ludwig Schwarzmayr; Hans Rotheneder
Journal:  Cell Cycle       Date:  2011-07-01       Impact factor: 4.534

View more
  25 in total

1.  The Dual Nature of Nek9 in Adenovirus Replication.

Authors:  Richard Jung; Sandi Radko; Peter Pelka
Journal:  J Virol       Date:  2015-12-16       Impact factor: 5.103

Review 2.  Roseomics: a blank slate.

Authors:  Nathaniel J Moorman; Eain A Murphy
Journal:  Curr Opin Virol       Date:  2014-11-28       Impact factor: 7.090

3.  The Epstein-Barr Virus BMRF1 Protein Activates Transcription and Inhibits the DNA Damage Response by Binding NuRD.

Authors:  Samuel G Salamun; Justine Sitz; Carlos F De La Cruz-Herrera; Jaime Yockteng-Melgar; Edyta Marcon; Jack Greenblatt; Amelie Fradet-Turcotte; Lori Frappier
Journal:  J Virol       Date:  2019-10-29       Impact factor: 5.103

4.  The DNA deaminase APOBEC3B interacts with the cell-cycle protein CDK4 and disrupts CDK4-mediated nuclear import of Cyclin D1.

Authors:  Jennifer L McCann; Madeline M Klein; Evelyn M Leland; Emily K Law; William L Brown; Daniel J Salamango; Reuben S Harris
Journal:  J Biol Chem       Date:  2019-06-19       Impact factor: 5.157

5.  G1/S Cell Cycle Induction by Epstein-Barr Virus BORF2 Is Mediated by P53 and APOBEC3B.

Authors:  Jaime Yockteng-Melgar; Kathy Shire; Adam Z Cheng; Natasha Malik-Soni; Reuben S Harris; Lori Frappier
Journal:  J Virol       Date:  2022-09-07       Impact factor: 6.549

6.  Epstein-Barr Virus (EBV) Tegument Protein BGLF2 Suppresses Type I Interferon Signaling To Promote EBV Reactivation.

Authors:  XueQiao Liu; Tomohiko Sadaoka; Tammy Krogmann; Jeffrey I Cohen
Journal:  J Virol       Date:  2020-05-18       Impact factor: 5.103

7.  Epstein-Barr Virus (EBV) Tegument Protein BGLF2 Promotes EBV Reactivation through Activation of the p38 Mitogen-Activated Protein Kinase.

Authors:  XueQiao Liu; Jeffrey I Cohen
Journal:  J Virol       Date:  2015-11-11       Impact factor: 5.103

8.  A Screen for Epstein-Barr Virus Proteins That Inhibit the DNA Damage Response Reveals a Novel Histone Binding Protein.

Authors:  Ting-Hin Ho; Justine Sitz; Qingtang Shen; Ariane Leblanc-Lacroix; Eric I Campos; Ivan Borozan; Edyta Marcon; Jack Greenblatt; Amelie Fradet-Turcotte; Dong-Yan Jin; Lori Frappier
Journal:  J Virol       Date:  2018-06-29       Impact factor: 5.103

9.  Identification of anti-Epstein-Barr virus (EBV) antibody signature in EBV-associated gastric carcinoma.

Authors:  Lusheng Song; Minkyo Song; M Constanza Camargo; Jennifer Van Duine; Stacy Williams; Yunro Chung; Kyoung-Mee Kim; Jolanta Lissowska; Armands Sivins; Weimin Gao; Kailash Karthikeyan; Jin Park; Marcis Leja; Jeffrey I Cohen; Joshua LaBaer; Ji Qiu; Charles S Rabkin
Journal:  Gastric Cancer       Date:  2021-03-04       Impact factor: 7.701

10.  Suppression of JAK-STAT Signaling by Epstein-Barr Virus Tegument Protein BGLF2 through Recruitment of SHP1 Phosphatase and Promotion of STAT2 Degradation.

Authors:  Michael George Botelho; Kit-San Yuen; Dong-Yan Jin; Sonia Jangra; Aradhana Bharti; Wai-Yin Lui; Vidyanath Chaudhary
Journal:  J Virol       Date:  2021-07-28       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.